Clean Science and Technology Limited (NSE:CLEAN)
India · Delayed Price · Currency is INR | Market Cap | 84.76B -32.9% |
| Revenue (ttm) | 9.57B -1.0% |
| Net Income | 2.30B -13.1% |
| EPS | 21.60 -13.2% |
| Shares Out | 106.28M |
| PE Ratio | 36.92 |
| Forward PE | 30.54 |
| Dividend | 6.00 (0.75%) |
| Ex-Dividend Date | Feb 6, 2026 |
| Volume | 1,562,445 |
| Open | 757.00 |
| Previous Close | 756.55 |
| Day's Range | 757.00 - 817.60 |
| 52-Week Range | 652.00 - 1,600.00 |
| Beta | 0.26 |
| Analysts | Buy |
| Price Target | 977.50 (+22.57%) |
| Earnings Date | May 14, 2026 |
About NSE:CLEAN
Clean Science and Technology Limited, together with its subsidiaries, manufactures fine and specialty chemicals in India, China, the Americas, Europe, and internationally. It operates through Performance Chemicals, FMCG Chemicals, and Pharmaceutical & Agro Intermediates segments. The company offers performance chemicals, including monomethyl ether of hydroquinone, butylated hydroxy anisole, tertiary butyl hydroquinone, hindered amine light stabilisers, and butylated hydroxytoluene, as well as clean antiOX 962, 4-oxo tempo, 4-butoxy tempo, clean... [Read more]
Financial Performance
In fiscal year 2026, NSE:CLEAN's revenue was 9.57 billion, a decrease of -1.04% compared to the previous year's 9.67 billion. Earnings were 2.30 billion, a decrease of -13.14%.
Financial StatementsNews
Clean Science and Technology Transcript: Q4 25/26
Q4 FY 2026 saw sequential revenue and margin improvement, led by record HALS sales and strong export growth. Backward integration and capacity expansion are underway, while global volatility and competition remain key risks. Dividend of INR 4/share declared.
Clean Science and Technology Quarterly report: Q4 2026
Clean Science and Technology has published its Q4 2026 quarterly earnings report on May 14, 2026.
Clean Science and Technology Slides: Q4 2026
Clean Science and Technology has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 14, 2026.
Clean Science and Technology Transcript: Q3 25/26
Q3 FY26 saw revenue and margins decline due to weak demand, pricing pressure, and tariffs, but HALS business grew 55% YoY and new plants are expected to improve margins. CapEx projects are on track, and management remains focused on long-term growth despite ongoing market headwinds.
Clean Science and Technology Quarterly report: Q3 2026
Clean Science and Technology has published its Q3 2026 quarterly earnings report on January 31, 2026.
Clean Science and Technology Slides: Q3 2026
Clean Science and Technology has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on January 31, 2026.
Clean Science and Technology Transcript: Q2 25/26
Revenue and profit declined due to lower volumes and competitive pressures, but EBITDA margins remained robust. Health segment showed strong sequential growth, new products were commercialized, and capacity expansions are underway. Market uncertainties and tariffs continue to pose risks.
Clean Science and Technology Quarterly report: Q2 2026
Clean Science and Technology has published its Q2 2026 quarterly earnings report on November 6, 2025.
Clean Science and Technology Slides: Q2 2026
Clean Science and Technology has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 6, 2025.
Clean Science and Technology Transcript: Q1 25/26
Q1 FY26 saw resilient margins despite a 9% sequential revenue drop, with record-high standalone EBITDA margin over 46%. New product launches and CapEx investments are set to drive growth, though guidance is moderated to 15%-18% EBITDA growth for FY26.
Clean Science and Technology Quarterly report: Q1 2026
Clean Science and Technology has published its Q1 2026 quarterly earnings report on July 17, 2025.
Clean Science and Technology Slides: Q1 2026
Clean Science and Technology has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on July 17, 2025.